AC
Adam Crystal (President, R&D) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Tango Therapeutics, Inc. (TNGX). The largest single filing was $962K of TNGX (38,460 sh × $25.00, as filed), executed Apr 15. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
12
0 buys · 12 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.9M
shares × price, as filed
Last traded
Oct 1
Filed Oct 5
Median ADV $98.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Sector per market data · by filing · past 12 months
Most traded names
TNGXRecent filings
TNGXSALE
Tango Therapeutics, Inc.
View filing →
$646K26,400 sh × $24.45
Exec Oct 1
Filed Oct 5 · 5:36 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $604K
27,000 sh × $22.37
Exec Sep 1
Filed Sep 3 · 4:01 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $736K
27,000 sh across 2 lots
Exec Aug 3
Filed Aug 5 · 4:01 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $799K
27,000 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 7:23 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $618K
27,000 sh across 2 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $549K
25,900 sh × $21.19
Exec May 1
Filed May 5 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $962K
38,460 sh × $25.00
Exec Apr 15
Filed Apr 16 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $572K
27,000 sh × $21.20
Exec Apr 1
Filed Apr 2 · 5:30 PM ET More filings →